Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_assertion type Assertion NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_head.
- NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_assertion description "[EphA2 was overexpressed in 80% of ovarian cancer cell lines and in 75% of clinical specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_provenance.
- NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_assertion evidence source_evidence_literature NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_provenance.
- NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_assertion SIO_000772 16969087 NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_provenance.
- NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_assertion wasDerivedFrom befree-2016 NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_provenance.
- NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_assertion wasGeneratedBy ECO_0000203 NP569025.RAsajvKaRVMhbT7_yQ77zDRAmB5kVcmEO-thsfj_-IqA4130_provenance.